Evidence-based recommendations regarding risk reduction practices for people at risk of or with breast cancer-related lymphedema: consensus from an expert panel.
Breast cancer
Consensus
Expert panel
Lymphedema
Precautionary behaviors
Risk reduction
Journal
Medical oncology (Northwood, London, England)
ISSN: 1559-131X
Titre abrégé: Med Oncol
Pays: United States
ID NLM: 9435512
Informations de publication
Date de publication:
23 Oct 2024
23 Oct 2024
Historique:
received:
27
06
2024
accepted:
18
09
2024
medline:
23
10
2024
pubmed:
23
10
2024
entrez:
22
10
2024
Statut:
epublish
Résumé
Several recent studies have investigated the validity of precautionary practices for lymphedema risk reduction after breast cancer treatment, such as avoidance of blood pressure measurements, skin puncture, blood draws, and use of prophylactic compression during air travel. Other studies have elucidated risk factors for breast cancer-related lymphedema, such as axillary lymph node dissection and skin infection (cellulitis). Combining the current evidence base with the consensus opinion of lymphatic experts assembled at the American Cancer Society/Lymphology Association of North America Summit in October 2023, updated evidence-based risk reduction recommendations are presented for those with or at risk of breast cancer-related lymphedema. Recommendation topics include prospective surveillance, patient education, individual risk factors, exercise, blood pressure, skin care and hygiene, skin puncture and blood draws, surgical procedures, prophylactic compression, air travel, and hot climate and sauna. These recommendations will help inform education and medical choices for individuals treated for breast cancer who are at risk of or diagnosed with breast cancer-related lymphedema. More high-quality evidence is required to allow the development of risk reduction recommendations for other cancer types such as gynecological, melanoma, and head and neck. It is recommended that clinicians and organizations serving people at risk of or with lymphedema align risk reduction guidelines with the evidence-based recommendations provided within this consensus document and companion manuscripts from the American Cancer Society/Lymphology Association of North America Lymphedema Summit: Forward Momentum: Future Steps in Lymphedema Management.
Identifiants
pubmed: 39438352
doi: 10.1007/s12032-024-02510-6
pii: 10.1007/s12032-024-02510-6
doi:
Types de publication
Journal Article
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
298Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Hunley, J., Doubblestein, D., & Campione, E. (2024). Current evidence on patient precautions for reducing lymphedema manifestation and progression risks. Medical Oncology, In Press
Boyages J, Vicini FA, Manavi BA, Gaw RL, Koelmeyer LA, Ridner SH, Shah C. Axillary treatment and chronic breast cancer-related lymphedema: implications for prospective surveillance and intervention from a randomized controlled trial. JCO Oncol Pract. 2023. https://doi.org/10.1200/OP.23.00060 .
doi: 10.1200/OP.23.00060
pubmed: 37816208
McDuff SGR, Mina AI, Brunelle CL, Salama L, Warren LEG, Abouegylah M, Swaroop M, Skolny MN, Asdourian M, Gillespie T, Daniell K, Sayegh HE, Naoum GE, Zheng H, Taghian AG. Timing of lymphedema after treatment for breast cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys. 2019;103(1):62–70. https://doi.org/10.1016/j.ijrobp.2018.08.036 .
doi: 10.1016/j.ijrobp.2018.08.036
pubmed: 30165125
Naoum GE, Roberts S, Brunelle CL, Shui AM, Salama L, Daniell K, Gillespie T, Bucci L, Smith BL, Ho AY, Taghian AG. Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. In J Clin Oncol. 2020. https://doi.org/10.1200/JCO.20.00459 .
doi: 10.1200/JCO.20.00459
Koelmeyer LA, Gaitatzis K, Dietrich MS, Shah CS, Boyages J, McLaughlin SA, Taback B, Stolldorf DP, Elder E, Hughes TM, French JR, Ngui N, Hsu JM, Moore A, Ridner SH. Risk factors for breast cancer–related lymphedema in patients undergoing 3 years of prospective surveillance with intervention. Cancer. 2022;128(18):3408–15. https://doi.org/10.1002/cncr.34377 .
doi: 10.1002/cncr.34377
pubmed: 35797441
Asdourian MS, Swaroop MN, Sayegh HE, Brunelle CL, Mina AI, Zheng H, Skolny MN, Taghian AG. Association between precautionary behaviors and breast cancer-related lymphedema in patients undergoing bilateral surgery. J Clin Oncol. 2017. https://doi.org/10.1200/JCO.2017.73.7494 .
doi: 10.1200/JCO.2017.73.7494
pubmed: 28976793
pmcid: 5721227
Ferguson CM, Swaroop MN, Horick N, Skolny MN, Miller CL, Jammallo LS, Brunelle C, O’Toole JA, Salama L, Specht MC, Taghian AG. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34(7):691–8. https://doi.org/10.1200/JCO.2015.61.5948 .
doi: 10.1200/JCO.2015.61.5948
pubmed: 26644530
Ribeiro Pereira ACP, Koffman R, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast. 2017;36:67–73.
doi: 10.1016/j.breast.2017.09.006
pubmed: 28992556
Showalter SL, Brown JC, Cheville AL, Fisher CS, Sataloff D, Schmitz KH. Lifestyle risk factors associated with arm swelling among women with breast cancer. Ann Surg Oncol. 2013. https://doi.org/10.1245/s10434-012-2631-9 .
doi: 10.1245/s10434-012-2631-9
pubmed: 23135311
Brunelle CL, Roberts SA, Shui AM, Gillespie TC, Daniell KM, Naoum GE, Taghian A. Patients who report cording after breast cancer surgery are at higher risk of lymphedema: results from a large prospective screening cohort. J Surg Oncol. 2020;122(2):155–63. https://doi.org/10.1002/jso.25944 .
doi: 10.1002/jso.25944
pubmed: 32497273
pmcid: 7369228
Montagna G, Zhang J, Sevilmedu V. Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema. JAMA Oncol. 2022;8(8):1195–200.
doi: 10.1001/jamaoncol.2022.1628
pubmed: 35679026
pmcid: 9185510
Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010;304(24):2699–705. https://doi.org/10.1001/jama.2010.1837 .
doi: 10.1001/jama.2010.1837
pubmed: 21148134
Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med. 2009;361(7):664–73. https://doi.org/10.1056/NEJMoa0810118 .
doi: 10.1056/NEJMoa0810118
pubmed: 19675330
Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Ung OA, Dylke ES, French JR, Yee J, Koelmeyer L, Gaitatzis K. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast. 2016;28:29–36. https://doi.org/10.1016/j.breast.2016.04.011 .
doi: 10.1016/j.breast.2016.04.011
pubmed: 27183497
Paramanandam VS, Dylke E, Clark GM, Daptardar AA, Kulkarni AM, Nair NS, Badwe RA, Kilbreath SL. Prophylactic use of compression sleeves reduces the incidence of arm swelling in women at high risk of breast cancer-related lymphedema: a randomized controlled trial. J Clin Oncol. 2022. https://doi.org/10.1200/JCO.21 .
doi: 10.1200/JCO.21
pubmed: 35108031
Phillips J, Witt S, Piller N, Gordon S. Seasonal variation in upper limb size, volume, fluid distribution, and lymphedema diagnosis, following breast cancer. Lymphat Res Biol. 2023;21(4):351–8.
doi: 10.1089/lrb.2022.0017
pubmed: 36812466
Czerniec S, Ward L, Kilbreath S. Breast cancer-related arm lymphedema: fluctuations over six months and the effects of the weather. Lymphat Res Biol. 2016;14(3):148–55.
doi: 10.1089/lrb.2015.0030
pubmed: 27266807